Inhibitory effects of flavonoids on aldehyde oxidase activity

References

• C Beedham. Molybdenum hydroxylases. In: C Ioannides, editor. Enzyme systems that metabolites drugs and other xenobiotics. New York: John Wiley;. (2002). p 147–148.
   Google Scholar
• C Beedham. Molybdenum hydroxylases: Biological distribution and substrate-inhibitor specificity. In: GP Ellis, and GP West, editors. Progress in medicinal chemistry. Amsterdam: Elsevier Science Publishers (Biomedical Division); (1987). p 58–127.
   Google Scholar
• C Beedham. Molybdenum hydroxylase. In: JW Gorrod, editor. Metabolism of xenobiotics. London and New York: Taylor & Francis; (1998). p 51–58.
   Google Scholar
• M Stanulovic, and S Chaykin. (1971). Aldehyde oxidase: Catalysis of the oxidation of N1-methylnicotinamide and pyridoxal. Arch Biochem Biophys 145:27–34.
   PubMed Web of Science ®Google Scholar
• W Ambroziak, G Izaguirre, and R Pietruszko. (1999). Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney. J Biol Chem 274:33366–33373.
   PubMed Web of Science ®Google Scholar
• Y Moriwaki, T Yamamoto, J Yamakita, S Takahashi, Z Tsutsumi, and K Higashino. (1998). Zonal distribution of allopurinol-oxidizing enzymes in rat liver. Adv Exp Med Biol 431:47–50.
   PubMedGoogle Scholar
• G Panoutsopoulos. (2005). Metabolism of homovanillamine to homovanillic acid in guinea pig liver slices. Cell Physiol Biochem 15:225–232.
   PubMed Web of Science ®Google Scholar
• MR Rashidi, JA Smith, SE Clarke, and C Beedham. (1997). In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug Metab Dispos 25:805–813.
   PubMed Web of Science ®Google Scholar
• CG Jordan, MR Rashidi, H Laljee, SE Clarke, JE Brown, and C Beedham. (1999). Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man. J Pharm Pharmacol 51:411–418.
   PubMed Web of Science ®Google Scholar
• C Beedham, Y al-Tayib, and JA Smith. (1992). Role of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials. Drug Metab Dispos 20:889–895.
   PubMed Web of Science ®Google Scholar
• DJ Critchley, DJ Rance, and C Beedham. (1994). Biotransformation of carbazeran in guinea pig: Effect of hydralazine pretreatment. Xenobiotica 24:37–47.
   PubMed Web of Science ®Google Scholar
• BG Lake, SE Ball, J Kao, AB Renwick, RJ Price, and JA Scatina. (2002). Metabolism of zaleplon by human liver: Evidence for involvement of aldehyde oxidase. Xenobiotica 32:835–847.
   PubMed Web of Science ®Google Scholar
• K Sugihara, Y Tayama, K Shimomiya, D Yoshimoto, S Ohta, and S Kitamura. (2006). Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridines, and interspecies variation of the enzyme activity in rats. Drug Metab Dispos 34:208–212.
   PubMed Web of Science ®Google Scholar
• S Brandange, and L Lindblom. (1979). The enzyme “aldehyde oxidase” is an iminium oxidase. Reaction with nicotine delta 1′(5′) iminium ion. Biochem Biophys Res Commun 91:991–996.
   PubMed Web of Science ®Google Scholar
• B Rochat, M Kosel, G Boss, B Testa, M Gillet, and P Baumann. (1998). Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver. Biochem Pharmacol 56:15–23.
   PubMed Web of Science ®Google Scholar
• PC Ruenitz, and X Bai. (1995). Acidic metabolites of tamoxifen. Aspects of formation and fate in the female rat. Drug Metab Dispos 23:993–998.
   PubMed Web of Science ®Google Scholar
• S Kitamura, KNK Ohashi, K Sugihara, R Hosokawa, Y Akagawa, and S Ohta. (2001). Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver. Biol Pharm Bull 24:856–859.
   PubMed Web of Science ®Google Scholar
• SC Lee, and AG Renwick. (1995). Sulphoxide reduction by rat and rabbit tissues in vitro. Biochem Pharmacol 49:1557–1565.
   PubMedGoogle Scholar
• K Tatsumi, H Yamada, and S Kitamura. (1983). Evidence for involvement of liver aldehyde oxidase in reduction of nitrosamines to the corresponding hydrazine. Chem Pharm Bull 31:764–767.
   PubMed Web of Science ®Google Scholar
• K Tatsumi, S Kitamura, and H Yamada. (1983). Sulfoxide reductase activity of liver aldehyde oxidase. Biochem Biophys Acta 747:86–92.
   PubMed Web of Science ®Google Scholar
• RS Obach. (2004). Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 32:89–97.
   PubMed Web of Science ®Google Scholar
• R Hille. (2005). Molybdenum-containing hydroxylases. Arch Biochem Biophys 433:107–116.
   PubMed Web of Science ®Google Scholar
• RJ Nijveldt, E van Nood, DEC van Hoorn, PG Boelens, K van Norren, and PAM van Leeuwen. (2001). Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418–425.
   PubMed Web of Science ®Google Scholar
• DE Van Hoorn, RJ Nijveldt, PA Van Leeuwen, Z Hofman, L M'Rabet, DB De Bont, and et al (2002). Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 451:111–118.
   PubMed Web of Science ®Google Scholar
• J Aucamp, A Gaspar, Y Hara, and Z Apostolides. (1997). Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res 17:4381–4385.
   PubMed Web of Science ®Google Scholar
• CM Lin, CS Chen, CT Chen, YC Liang, and JK Lin. (2002). Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun 294:167–172.
   PubMed Web of Science ®Google Scholar
• J Hanaee, MR Rashidi, A Delazar, and S Pirouzpanah. (2004). Onion, a potent inhibitor of xanthine oxidase. Iran J Pharm Res 4:243–247.
   Google Scholar
• A Nagao, M Seki, and H Kobayashi. (1999). Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol Biochem 63:1787–1790.
   PubMed Web of Science ®Google Scholar
• N Cotelle. (2001). Role of flavonoids in oxidative stress. Curr Top Med Chem 1:569–590.
   PubMedGoogle Scholar
• S Kitamura, K Sugihara, and S Ohta. (2006). Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab Pharmacokinet 21:83–98.
   PubMed Web of Science ®Google Scholar
• Z Yu, WP Fong, and CH Cheng. (2006). The dual actions of morin (3,5,7,2′,4′-pentahydroxyflavone) as a hypouricemic agent: Uricosuric effect and xanthine oxidase inhibitory activity. J Pharmacol Exp Ther 316:169–175.
   PubMed Web of Science ®Google Scholar
• S Pirouzpanah, MR Rashidi, A Delazar, SV Razavieh, and A Hamidi. (2006). Inhibitory effects of Ruta graveolens L. Extract on guinea pig liver aldehyde oxidase. Chem Pharm Bull 54:9–13.
   PubMed Web of Science ®Google Scholar
• PK Smith, RI Krohn, GT Hermanson, AK Mallia, FH Gartner, MD Provenzano, EK Fujimoto, NM Goeke, BJ Olson, and DC Klenk. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85.
   PubMed Web of Science ®Google Scholar
• AA Aziz, CA Edwards, MEJ Lean, and A Crozier. (1998). Absorption and excretion of conjugated flavonols, including quercetin-4′-O-β-glucoside and isorhamnetin-4′-O-β-glucoside by human volunteers after the consumption of onions. Free Rad Res 29:257–269.
   PubMed Web of Science ®Google Scholar
• GT McAnlis, J McEneny, J Pearce, and IS Young. (1999). Absorption and antioxidant effects of quercetin from onions, in man. Eur J Clin Nutr 53:92–96.
   PubMed Web of Science ®Google Scholar
• Y Zhang, Q Zhang, L Li, B Wang, Y Zhao, and D Guo. (2007). Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction. J Chromatogr B 860:4–9
   Google Scholar
• K Huh, US Shin, JW Choi, and SI Lee. (1994). Effect of sex hormones on lipid peroxidation in rat liver. Arch Pharmacol Res 17:109–114.
   PubMedGoogle Scholar
• DU Lee, US Shin, and K Huh. (1998). Structure-activity relationships of gagaminine and its derivatives on the inhibition of hepatic aldehyde oxidase activity and lipid peroxidation. Arch Pharmacol Res 21:273–277.
   PubMed Web of Science ®Google Scholar